Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Prix Galien opens for entries with new award

2018 programme will include new medical technology category

- PMLiVE

NICE: We’re the institute of ‘yes’

But Meindert Boysen says affordability conversations with pharma need to happen earlier

- PMLiVE

AZ buoyed by latest lung cancer data at ESMO

Data from separate Tagrisso and Imfinzi trials show superior PFS among patients

Tightening medical device safety

European legislators seek to reduce patient exposure to safety risks

Life lessons

The recent problems of the generics sector have lessons for research-based companies too

FDA poised to start digital health pilot

Forms a key part of the agency's new digital innovation action plan

Eli Lilly HQ

Lilly axes 3,500 jobs in $500m-a-year cost-cutting drive

US drug maker to slash its workforce by 8.5%

Bristol-Myers Squibb (BMS) building

BMS’ Opdivo and Yervoy ace kidney cancer trial

Combined checkpoint inhibitors show improved survival versus standard therapy

- PMLiVE

Vertex poaches new finance chief from Ironwood Pharmaceuticals

Boston-based biotech company appoints Tom Graney

- PMLiVE

Are we #winning?

Is healthcare fully embracing the Digital Opinion Leader (DOL)?

- PMLiVE

GSK and Novartis lead at PM Society Digital Awards

And agency-side Health Hive Group, the Earthworks and 90TEN topped the charts

Roche Basel Switzerland

UK is first to receive Roche’s rare lung cancer drug

Alecensa made available under MHRA's early access scheme

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links